Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL698354 | 1.00 | DPP4 (0.51) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL12445155 | 0.88 | CYP2A6 (0.45) | DPP4ALDH1A1KDM4EL3MBTL1NPC1 | |
| SCHEMBL19165108 | 0.88 | CYP2A6 (0.45) | DPP4ALDH1A1KDM4EL3MBTL1NPC1 | |
| SCHEMBL723960 | 0.86 | CYP2A6 (0.44) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL498545 | 0.86 | CYP2A6 (0.47) | ALDH1A1KDM4EL3MBTL1LMNAMAPT | |
| Benzene SCHEMBL28459864 | 0.84 | CYP2A6 (0.43) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL13156364 | 0.81 | DPP4 (0.50) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL13125591 | 0.80 | DPP4 (0.46) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL23611278 | 0.79 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EGAA | |
| SCHEMBL2742433 | 0.79 | DPP4 (0.65) | DPP4LTA4HALDH1A1KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5415893-A | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1995-05-16 | — | — | US | claimed |
| US-8106038-B2 | Method for reducing or preventing PDT related inflammation | QLT INC. (CA) | 2012-01-31 | — | — | US | disclosed |
| US-8034803-B2 | Treating an occult choroidal neovascular lesion | QLT INC. (CA) | 2011-10-11 | — | — | US | disclosed |
| US-20030087889-A1 | Photodynamic therapy of occult age-related macular degeneration | BAUSCH HEALTH COMPANIES INC. (CA) | 2003-05-08 | — | — | US | disclosed |
| US-20030083649-A1 | Method for reducing or preventing PDT related inflammation | VALEANT SP. Z.O.O. (PL) | 2003-05-01 | — | — | US | disclosed |
| US-6315926-B1 | HAZE-FREE | DSM N.V. (NL) | 2001-11-13 | — | — | US | disclosed |
| EP-0261837-B1 | Process for the preparation of electrically conductive material | SANYO ELECTRIC CO (JP) | 2001-07-11 | — | — | EP | disclosed |
| EP-0821041-B1 | Aqueous coating dispersion, process for the preparation thereof and use thereof in an anticorrosive paint | DSM NV (NL) | 2001-04-11 | — | — | EP | disclosed |
| US-5993695-A | ELECTROCONDUCTIVE PARTICLES COMPRISE AT LEAST A FIRST BINDER, A CONDUCTIVE POLYMER AND A NON-IONIC STABILIZER, CHARACTERIZED IN THAT THE COATING DISPERSION CONTAINS A SECOND BINDER DOES NOT FORM PART OF THE ELECTRICALLY CONDUCTIVE PARTICLES. | DSM N.V. (NL) | 1999-11-30 | — | — | US | disclosed |
| EP-0821040-A1 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0821041-A2 | Aqueous coating dispersion, process for the preparation thereof and use thereof in anticorrosive paint | DSM N.V. (NL) | 1998-01-28 | — | — | EP | disclosed |
| EP-0342998-B1 | Process for manufacturing an electrode for a solid electrolytic capacitor | SANYO ELECTRIC CO (JP) | 1996-01-17 | — | — | EP | disclosed |
| US-5415893-A | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1995-05-16 | — | — | US | disclosed |
| EP-0219063-B1 | Process of manufacturing an electrically conductive material and a secondary battery using the electrically conductive material | SANYO ELECTRIC CO (JP) | 1994-04-06 | — | — | EP | disclosed |
| EP-0589529-A1 | Dispersion of electrically conductive particles in a dispersing medium | DSM N.V. (NL) | 1994-03-30 | — | — | EP | disclosed |
| US-5019949-A | Solid electrolytic capacitor | SANYO ELECTRIC CO., LTD. (JP) | 1991-05-28 | — | — | US | disclosed |
| US-4795687-A | POLYTHIENYLENE, POLYPRYRROLE OR POLYANILINE MATERIAL PREPARED BY OXIDATION POLYMERIZATION | MITSUBISHI KASEI CORP. (JP) | 1989-01-03 | — | — | US | disclosed |
| EP-0261837-A2 | Electrically conductive material and a process for the preparation of same and secondary battery using the electrically conductive material | Sanyo Electric Co., Ltd (JP) | 1988-03-30 | — | — | EP | disclosed |
| EP-0219063-A2 | Process of manufacturing an electrically conductive material and a secondary battery using the electrically conductive material | Sanyo Electric Co., Ltd (JP) | 1987-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030087889-A1 | Photodynamic therapy of occult age-related macular degeneration | ALDH1A2, AGER, CRY2 | DPP4 158/4885LTA4H 1026/4885ALDH1A1 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.